Application of SERS Technology in Clinical Diagnosis and Prognosis of Lung Cancer Immunotherapy
NCT05885815
·
clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China